Rosenblatt Affirms Buy on Broadcom, $600 Price Target

Analyst: Sajal Dogra 1 min read Reproduced verbatim
Rating
Buy
Unchanged
Target
$600
Unchanged
Upside
+75%
AVGO at $342 today
Rosenblatt and Broadcom logos

What the analyst said

Rosenblatt analyst Sajal Dogra reiterated a Buy rating and $600 price target on Broadcom Limited (NASDAQ: AVGO).

“Broadcom announced a $63B financing transaction to support Anthropic’s CY27 compute deployments.

The financing covers four sites across four U.S. states and follows the $35B CY26 transaction, supporting Anthropic’s planned 1GW/5GW/10GW ramp across CY26/CY27/CY28.

It funds only part of Anthropic’s CY27 requirements, leaving additional financing ahead. We view this as a positive execution milestone for Anthropic’s committed ramp.

With financing increasingly constraining AI deployment, Broadcom is using its balance sheet to support chip sales while earning ~200bps on the supported balance.

Broadcom sells chips to an SPV that leases capacity to Anthropic, recognizing revenue upon delivery and acceptance. The fee is separate from chip ASPs.

The trade-off is meaningful contingent exposure, which could grow even as the required backstop percentage declines.

The RVS backstop functions economically as a bridge until Anthropic can finance compute needs independently.

Hock expects improving Anthropic creditworthiness to expand the capital available without Broadcom’s support, potentially reducing or eliminating backstops on future transactions.

We maintain our Buy rating and $600 price target, based on 18x our FY28 Non-GAAP EPS estimate.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

AVGO trades at $342. The 21 analysts who set a target in the last 3 months range from $400 to $630, with a median of $515. This $600 target is 17% above the median.

12-month window: day 0 of 365, closes on October 27, 2027.

Track record

This callOpen: AVGO has not reached $600 yet. This 12-month target is scored on September 3, 2027. Same target as this firm’s September 3, 2026 note, so it is scored there.

Firm track recordRosenblatt: 80% of its 10 targets at least a year old were reached within 12 months. Accuracy ranking →

Rosenblatt on Broadcom

Rosenblatt price targets on Broadcom

3 calls from March 5, 2026 to October 27, 2026. The target went from $500 to $600 (+20%). The rating stayed Buy.

Rosenblatt targetAVGO share price
  1. October 27, 2026 This noteKept the $600 targetBuy$600
  2. September 3, 2026Target raised from $500 (+20%)Buy$600
  3. March 5, 2026Earliest call shownBuy$500
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.